scholarly journals Ogilvie’s syndrome—is there a cutoff diameter to proceed with upfront surgery?

2022 ◽  
Author(s):  
Katharina Joechle ◽  
Jessica Guenzle ◽  
Stefan Utzolino ◽  
Stefan Fichtner-Feigl ◽  
Lampros Kousoulas
Keyword(s):  
Overall Survival ◽  
Endoscopic Treatment ◽  
Therapeutic Strategy ◽  
Conservative Therapy ◽  
Endoscopic Therapy ◽  
Endoscopic Management ◽  
Ogilvie's Syndrome ◽  
Therapeutic Success ◽  
Ogilvie’S Syndrome ◽  
Time Period

Abstract Purpose Although Ogilvie’s syndrome was first described about 70 years ago, its etiology and pathogenesis are still not fully understood. But more importantly, it is also not clear when to approach which therapeutic strategy. Methods Patients who were diagnosed with Ogilvie’s syndrome at our institution in a 17-year time period (2002–2019) were included and retrospectively evaluated regarding different therapeutical strategies: conservative, endoscopic, or surgical. Results The study included 71 patients with 21 patients undergoing conservative therapy, 25 patients undergoing endoscopic therapy, and 25 patients undergoing surgery. However, 38% of patients (n = 8) who were primarily addressed for conservative management failed and had to undergo endoscopy or even surgery. Similarly, 8 patients (32%) with primarily endoscopic treatment had to proceed for surgery. In logistic regression analysis, only a colon diameter ≥ 11 cm (p = 0.01) could predict a lack of therapeutic success by endoscopic treatment. Ninety-day mortality and overall survival were comparable between the groups. Conclusion As conservative and endoscopic management fail in about one-third of patients, a cutoff diameter ≥ 11 cm may be an adequate parameter to evaluate surgical therapy.

scholarly journals Endoscopic management of gastroesophageal reflux disease in 2012: What works and what doesn′t

2012 ◽  
Vol 03 (S 05) ◽  
pp. 013-016
Author(s):  
George Triadafilopoulos
Keyword(s):  
Gastroesophageal Reflux Disease ◽  
Gastroesophageal Reflux ◽  
Reflux Disease ◽  
Endoscopic Treatment ◽  
Endoscopic Therapy ◽  
Endoscopic Management ◽  
What Works ◽  
The Us ◽  
Multiple Devices ◽  
Antireflux Barrier

AbstractGastroesophageal reflux disease results primarily from the loss of an effective antireflux barrier, which forms a mechanical barrier against the retrograde movement of gastric contents. Multiple devices have been developed for the endoscopic treatment of GERD, using approaches such as sewing, transmural fasteners, endoscopic staplers, and thermal treatment. Devices that are currently commercially available for the endoscopic treatment of GERD in the US include: EndoCinch; EsophyX; Stretta. This article will highlight the endoscopic therapy of gastroesophageal reflux disease with focus on Stretta and EsophyX.

Ogilvie's syndrome presented with delirium in an older lady with corticobasal syndrome

2021 ◽  
pp. 1-3
Author(s):  
Feyza Mutlay ◽  
Derya Kaya ◽  
Ahmet Turan Isik
Keyword(s):  
Palliative Care ◽  
Health Care Professionals ◽  
Colonic Obstruction ◽  
Holistic Approach ◽  
Abdominal Distension ◽  
Corticobasal Syndrome ◽  
Ogilvie's Syndrome ◽  
Geriatric Population ◽  
Ogilvie’S Syndrome ◽  
Neurological Illnesses

Abstract Objective Corticobasal syndrome (CBS) is one of an atypical parkinsonian syndromes characterized by extrapyramidal features as well as cortical involvement signs. A variety of factors may lead to delirium in older adults with chronic progressive life-limiting neurological illnesses like CBS. Ogilvie's syndrome (OS) is an acute colonic pseudo-obstruction in which abdominal distension, nausea, vomiting, and constipation can be seen. We report a case of OS identified as the underlying possible cause of delirium in an 80-year-old woman with CBS. We also discuss the importance of holistic approach which is essential to manage the underlying cause and to preserve the quality of life in particular for the frail geriatric population who potentially needs palliative care or already benefits from palliative care. Method An older patient with CBS presented with symptoms similar to that of acute colonic obstruction and subsequently developed delirium. The patient was found to have colonic pseudo-obstruction (OS). Result Neostigmin infusion was therefore given to treat it and delirium was resolved. Significance of results To the best of our knowledge, clinical manifestation of delirium as OS in a patient with CBS has not been previously reported. OS may be superimposed to CBS in older patients, and OS in such patients may play a role as a precipitating factor for the development of delirium. Given the fact that CBS is progressive and rare neurodegenerative disease and almost all of these patients need palliative care, eventually, health-care professionals, especially in palliative care, should be aware of distinctive challenges of life-limiting chronic neurological illnesses, such as conditions that may lead to the development of acute colonic pseudo-obstruction because the rapid treatment of them prevents the use of potentially harmful drugs, surgical procedures, or inappropriate interventions.

The Potentially Fatal Ogilvie's Syndrome in Lateral Transpsoas Access Surgery: A Multi-Institutional Experience with 2930 Patients

2017 ◽  
Vol 99 ◽  
pp. 302-307 ◽  
Author(s):  
Jacob Januszewski ◽  
Sean K. Keem ◽  
William Smith ◽  
Joshua M. Beckman ◽  
Adam S. Kanter ◽  
...  
Keyword(s):  
Ogilvie's Syndrome ◽  
Ogilvie’S Syndrome ◽  
Institutional Experience ◽  
Access Surgery

Fr310 ASSESSMENT OF CLINICAL FAILURE AND OVERALL SURVIVAL IN PATIENTS UNDERGOING ENDOSCOPIC MANAGEMENT OF PANCREATIC FLUID COLLECTIONS

2021 ◽  
Vol 160 (6) ◽  
pp. S-294-S-295
Author(s):  
Robert Dorrell ◽  
Swati Pawa ◽  
Gregory B. Russell ◽  
Clancy J. Clark ◽  
Girish Mishra ◽  
...  
Keyword(s):  
Overall Survival ◽  
Endoscopic Management ◽  
Clinical Failure ◽  
Pancreatic Fluid Collections ◽  
Pancreatic Fluid ◽  
Fluid Collections

scholarly journals Survival and Disease Recurrence in Patients with Duodenal Neuroendocrine Tumours—A Single Centre Cohort

Cancers ◽  
2021 ◽  
Vol 13 (16) ◽  
pp. 3985
Author(s):  
Oddry Folkestad ◽  
Hans H. Wasmuth ◽  
Patricia Mjønes ◽  
Reidun Fougner ◽  
Øyvind Hauso ◽  
...  
Keyword(s):  
Overall Survival ◽  
Recurrence Rate ◽  
Surgical Resection ◽  
Endoscopic Treatment ◽  
Neuroendocrine Tumours ◽  
Disease Recurrence ◽  
Tumour Grade ◽  
Single Centre ◽  
Duodenal Neuroendocrine Tumours

Background: Duodenal neuroendocrine tumours (D-NETs) are rare but increasingly diagnosed. This study aimed to assess the overall survival and recurrence rate among patients treated for D-NETs. Methods: Patients with D-NETs were retrospectively reviewed with a median follow-up time of 4.8 years (range 0.0–17.2 years). Results: A total of 32 patients with median age 68.0 years were identified. Fifteen patients underwent surgery while ten patients underwent endoscopic treatment. Mean estimated overall survival for the entire population was 12.1 years (95% CI 9.5–14.7 years), while 5-year overall survival was 81.3%. Tumour grade G1 was associated with longer mean estimated survival compared to G2 tumours (13.2 years versus 4.4 years, p = 0.010). None of the 23 patients who underwent presumed radical endoscopic or surgical resection had disease recurrence during follow-up. Tumours <10 mm could be treated endoscopically whereas a high proportion of patients with tumours 10–20 mm should be considered for surgery. Conclusion: Patients with D-NETs had long overall survival, and mortality was more influenced by other diseases. Both endoscopic and surgical resections were effective as no recurrences were diagnosed during follow-up.

scholarly journals A case report of Ogilvie's syndrome in an ischemic stroke patient

2014 ◽  
Vol 20 (2) ◽  
pp. 65-68
Author(s):  
Ilay Hilal Kilic ◽  
Ilknur Donmez ◽  
Cihat Uzunkopru ◽  
Ayse Guler ◽  
Hadiye Sirin
Keyword(s):  
Ischemic Stroke ◽  
Case Report ◽  
Stroke Patient ◽  
Ischemic Stroke Patient ◽  
Ogilvie's Syndrome ◽  
Ogilvie’S Syndrome
Sign in / Sign up

Export Citation Format

Share Document